Skip to main content

In-Vitro Fertilization Market is predicted to grow at a CAGR of 9.37% during 2020-2030.

Healthcare specialists have located in-vitro fertilization to be one of the most hastily evolving techniques, and the world market for in-vitro fertilization is anticipated to develop at a CAGR of 9.37% over the forecast length 2020-2030. An make bigger in the fashion of delayed pregnancies, altering life in city areas, and accelerated age of parenthood bolster the increase of the world IVF market. The following record gives the reader with an possibility to liberate complete insights with respect to the international IVF market and helps in forming well-informed strategic decisions. The market lookup learn about additionally provides a vast standpoint of the one of a kind kinds of merchandise and offerings on hand in the market and their have an impact on on the healthcare zone through offering crucial insights into the path of its future expansion.

The market value estimated by 2030 will be $51,505.1 Million. The in-vitro fertilization market in the coming years is expected to grow at a CAGR of 9.37% during the forecast period from 2020-2030.



Market Segmentation

•    Component – Product, Services

•    Product – Systems, Media and Reagents, Accessories and Consumables

•    Services – Types, Procedures, End Users


Regional Segmentation

•    North America – U.S., Canada

•    Europe – Germany, France, Italy, U.K., Spain, Russia, Netherlands

•    Asia-Pacific – Japan, China, India, South Korea, Australia, Singapore

•    Latin America – Brazil, Mexico

•    Rest-of-the-World – the Middle East and Africa


Growth Drivers

•    Growth in Median Age of First-Time Motherhood and Declining Fertility Rates

•    High Success Rate of IVF Treatment

•    Increasing Demand for Infertility Treatment to Support Aging Population

•    Impact of Fertility Tourism


Market Challenges

•    Unaffordable Cost of Assisted Reproductive Techniques (ART) and Genetic Testing in Low- and Middle- Income Countries

•    Lack of Guidelines and Regulations, and Low Awareness of IVF Treatment in Some Under-Developed and Developing Nations

•    Ethical Issues and Social Justice


Market Opportunities

•    Technological Advancements of Time-Lapse Technology

•    Advances in Embryo Biopsy and Genetic Screening


Key In-Vitro Fertilization Companies Profiled

Suppliers - CooperSurgical, Inc., Vitrolife AB, Illumina, Inc., Agilent Technologies, Inc., Cook Medical Inc., Fujifilm Irvine Scientific Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Abbott Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Esco Micro Pte. Ltd., IVFtech APS, and Kitazato Corporation.

Service Providers - CARE Fertility, Laboratory Corporation of America Holdings, Genea Limited, Natera, Inc., Invitae Corporation, Kaiser Permanente, Progyny, Inc., Boston IVF, and Monash IVF Group.

Request a Sample - https://bisresearch.com/requestsample?id=1106&type=download


Comments

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Clinical Decision Support Systems (CDSS) Market registering a CAGR of 6.70% during the forecast period 2021-2030

The global market for clinical decision support systems (CDSS) registered the market value of $1,918.8 million in 2020 and is expected to reach $3,739.2 million by 2030, registering at a CAGR of 6.70% during the forecast period 2020-2030. The clinical decision support systems of the future are expected to be developed to leverage data to make observations which are not interpretable by humans. Healthcare IT systems in the future are expected to leverage cutting-edge technology as an enabler to make clinical care more streamlined and accurate. The technology is still in its nascent stage. One of the strong points of this technology is that it improves with time. Continuous input from clinicians, patients, and other stakeholders will be essential for correctly implementing the technology to enhance meaningful uses, reduce costs, and improve treatment outcomes. Key USPs of the Report Following are some of the key contents of the report: •     Industry Analysis    ...

Hyperspectral Imaging Market Projections , Upcoming Trends Focus on Long-Term Impact of Covid-19 and Forecast By 2027

  The global  hyperspectral imaging market  was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.The growth in the global hyperspectral imaging market is expected to be primarily driven by increased awareness of the technology in different sectors such as agriculture, healthcare, and mining. The hyperspectral imaging technology has great potential, and the market is anticipated to grow during the forecast period owing to the widespread applications of HSI, increasing investments for RD activities, increasing demand from military and defense sectors, increased food safety concerns, and increasing awareness regarding early diagnosis of diseases.   COVID-19 Impact and Post-COVID-19 Scenario The COVID-19 pandemic had a debilitating impact on the global ecosystem. The pandemic led to a shutdown of production facilities, which do not come under essential goods, which led to a negative impact on se...